Gene Logic Says Value of Assets from TherImmune Acquisition is Impaired, Lowers Revenue Expectations for Unit | GenomeWeb

NEW YORK, Sept. 23 (GenomeWeb News) - Gene Logic said yesterday that the value of the goodwill asset from its 2003 acquisition of TherImmune Research is impaired.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.